| John R Lageson, MD | |
|
705 Pleasant Ave S, Park Rapids, MN 56470-1440 | |
| (218) 732-2800 | |
| (218) 732-2857 |
| Full Name | John R Lageson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 705 Pleasant Ave S, Park Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437190188 | NPI | - | NPPES |
| 11815 | Other | MN | NDBS # |
| 9F26LA | Other | MN | MNBS # |
| 0402524 | Other | MN | MEDICA # |
| 10274 | Other | MN | NDBS # |
| 167225 | Other | MN | UCARE # |
| 904871 | Other | MN | AMERICA'S PPO/ARAZ # |
| DA9041015677 | Other | MN | PREFERRED ONE # |
| HP19534 | Other | MN | HEALTHPARTNERS # |
| 0402522 | Other | MN | MEDICA # |
| 0402523 | Other | MN | MEDICA # |
| MN100004 | Other | MN | LHS/BANNERHEALTH # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 31784 (Minnesota) | Secondary |
| 207R00000X | Internal Medicine | 31784 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Joseph's Area Health Services | Park rapids, MN | Hospice |
| St Josephs Area Health Services | Park rapids, MN | Hospital |
| Essentia Health | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Joseph's Area Health Services | 0345146510 | 7 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
| Entity Name | Unity Family Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326234006 PECOS PAC ID: 9830003516 Enrollment ID: O20031117000732 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20031209000521 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
| Entity Name | Unity Family Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1780630939 PECOS PAC ID: 9830003516 Enrollment ID: O20061104000248 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20061104000649 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John R Lageson, MD 705 Pleasant Ave S, Park Rapids, MN 56470-1440 Ph: (218) 732-2800 | John R Lageson, MD 705 Pleasant Ave S, Park Rapids, MN 56470-1440 Ph: (218) 732-2800 |
News Archive
Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.
"Utah's Medicaid rolls grew by 405 people in April, the smallest monthly increase since March 2008, the start of an unprecedented growth streak for the low-income health program. Unemployment has also slowed, which economists believe is an early sign of economic recovery" (Stewart, 5/17).
AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.
Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
› Verified 5 days ago
Nathan Phillip Harris, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 705 Pleasant Ave S, Park Rapids, MN 56470 Phone: 218-732-2800 Fax: 218-732-2874 | |
Larry M Leadbetter, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 705 Pleasant Ave S, Park Rapids, MN 56470 Phone: 218-732-2800 Fax: 218-732-2857 | |
Vern Erickson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 7th St W, Park Rapids, MN 56470 Phone: 218-732-7760 Fax: 218-732-7334 |